The JCI rebounded to about 7,000 after bottoming out at 5,968 on 9 April, following a series of developments including corporate buyback announcements, the creation of Danantara, and market anticipation of a BI rate cut which materialised on 21 May (25bp cut). Catalysts to monitor in 2H25 are further rate BI cut(s), a slowdown in SRBI reissuance which would free up banking liquidity, further government economic stimulus measures, and heavier government spending. • In need of a rate cut and an in...
We met with 12 investors in Kuala Lumpur, and the overall tone among Malaysian-based funds can be best described as cautious but engaged. Indonesia remains firmly on their radar, but several overhangs persist, particularly around the evolving political landscape, policy clarity, the free meal programme and weak purchasing power. 2H25 government spending and a further rate cut are catalysts, in our view. Our year-end target for the JCI is 7,500.
GREATER CHINA Sector Property Takeaways from channel check at The Southside. INDONESIA Strategy Higher Oil Prices Bode Well For Some Participants Beneficiaries of higher oil prices. Takeaways From Our Marketing Trip To Kuala Lumpur Cautious but engaged. MALAYSIA Sector Construction Sector resists tensions from global uncerta...
Strategy: Higher Oil Prices Bode Well For Some Market Participants: Beneficiaries of higher oil prices. Takeaways From Our Marketing Trip To Kuala Lumpur: Cautious but engaged. TRADERS’ CORNER Astra Agro Lestari (AALI IJ): Technical BUY Jasa Marga (JSMR IJ): Technical BUY
Liquidity remains tight with deposit growth slowing and industry LDR rising to 90% in Apr 25. Banks relied on BI repo facilities while the overnight rate has consistently surpassed BI rate in recent weeks. Nevertheless, we expect liquidity to improve in 2H25 due to the recent rate cut, lower PLM, and higher foreign borrowing limits. SRBI issuance has eased though it remains substantial. Expected higher fiscal spending in 2H25 could facilitate greater liquidity. Maintain OVERWEIGHT on the sector.
GREATER CHINA Strategy Alpha Picks: June Conviction Calls: Add Prudential and Sino Biopharm to our BUY list. Take profit on SHKP and Trip.com. INDONESIA Strategy Alpha Picks: Good Performances In May: Good performances from most with the exception of GOTO and BUKA. MALAYSIA Strategy Alpha Picks: Raising Emphasis On Infrastructure Plays: Our May 25 Alpha Picks outperformed with resounding success. June 25 picks: Duopharma, Eco World, Gamuda, Hume Cement, IJM, MYEG, Northeast Group. SINGAPORE S...
Banks showed mixed earnings, with BBCA and BRIS leading profit growth, while BBRI saw a decline in 1Q25. Loan growth was flat qoq due to tight liquidity and cautious loan disbursements. BBCA and BMRI had the best asset quality while BBRI faced elevated credit costs. The impact of the tariff war could be visible in 2Q25. Despite headwinds, banks remain fundamentally strong. We maintain OVERWEIGHT on expectations of: a) rate cuts, b) higher fiscal spending in 2H25, and c) reduced SRBI reissuance.
GREATER CHINA Strategy Alpha Picks: May Conviction Calls: Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. INDONESIA Strategy Alpha Picks: Outperformance In Apr 25: Remove ICBP, EXCL and MIKA; add BBTN and GOTO. MALAYSIA Strategy Alpha Picks: Capitalising On Sentiment Turnaround: Our Apr 25 Alpha Picks underperformed. May 25 picks: Duopharma, Gamuda, IJM, IOI Properties, TIME dotCom, MYEG, Nationgate, Northeast Group and RHB Bank. SINGAPO...
GREATER CHINA Economics Inflation Deflationary pressures remain. Sector Automobile Weekly: Direct impacts from US tariffs contained; indirect spillovers uncertain. Maintain MARKET WEIGHT on the sector. Top BUYs: BYD, Geely and Desay SV. Update Anta Sports (2020 HK/BUY/HK$81.55/Target: HK$108.80) 1Q25 sales me...
Indonesian banks face risks from global trade tensions through corporate borrowers, exporters and forex exposure. Historical data for 2012–24 shows banks' resilience during major shocks like COVID-19, the taper tantrum and the US-China trade war. Stress tests show that CAR remains above regulatory minimums even in severe scenarios, supported by strong capitalisation. Maintain OVERWEIGHT. BBCA is our top pick due to its robust CAR and ample liquidity. Tactical trades can be deployed around volati...
GREATER CHINA Strategy Alpha Picks: April Conviction Calls: Add CR Beer, Desay, JBM Healthcare, JD Logistics, Minth, WuXi App Tech and Xiaomi Corp to our BUY list. Take profit on AIA, Hansoh Pharma, JD and Zijin Mining. INDONESIA Strategy Alpha Picks: Outperform In Mar 25: Remove BBNI, BBRI, ASII, JSMR and KLBF; add BBCA, ICBP, ERAA and BUKA. MALAYSIA Strategy Alpha Picks: Pockets of Opportunities: Our Mar 25 Alpha Picks outperform. Apr 25 picks: Alpha IVF, Duopharma, IJM, IOI Properties, TIME...
BBRI, BMRI and BBNI raised their 2024 DPRs, with share buybacks planned while maintaining their high-teens capital buffer. SOE banks saw major leadership changes. Overall, PPOP was flat with mixed profit trends, and loan growth was strong at 10.3% yoy in Feb 25. Danantara’s new leadership, comprising experienced professionals, may boost investor confidence. Maintain OVERWEIGHT. Our top picks are: BBCA>BMRI>BBNI> BRIS>BBRI.
GREATER CHINA Results CR Land (1109 HK/BUY/HK$25.85/Target: HK$32.40) 2024: Results in line; positive outlook for property sales in 2025. CR Mixc (1209 HK/BUY/HK$34.50/Target: HK$38.70) 2024: Results beat with 100% payout ratio; pursuing high-quality growth. Giordano International (709 HK/BUY/HK$1.52/Target: HK$2.14) 2024: 2H24 revenue rebound; 3-5% revenue growth and improving net margin in 2025. Haidilao Internatio...
GREATER CHINA Results BYD Company (1211 HK/BUY/HK$389.20/Target: HK$510.00) 4Q24: Earnings up 73% yoy, beating our estimates on margins. Maintain BUY. Raise target price from HK$410.00 to HK$510.00. BYD Electronic (285 HK/BUY/HK$42.45/Target: HK$47.70) 2H24: Earnings miss on margins; future growth will be driven by automotive and AI. Maintain BUY. Kuaishou (1024 HK/BUY/HK$56.80/Target: HK$75.00) 4Q24: Results in line with...
After the significant management restructuring, investors are awaiting the strategies and initiatives of the newly-appointed directors. Given his vast experience, Mr. Hery is expected to bring valuable insights and strategies to BBRI. The AGM approved: a) an 85% DPR (up from 80% in 2023); and b) a share buyback of Rp3t. Although CoC is above guidance, it significantly declined in Feb 25, decelerating the drop in net profit growth to 18% yoy in 2M25 (1M25: -58%yoy). Maintain BUY. Target price: Rp...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.